Drug Shortage Report for PRIVA-MONTELUKAST
Report ID | 130176 |
Drug Identification Number | 02440350 |
Brand name | PRIVA-MONTELUKAST |
Common or Proper name | Montelukast |
Company Name | PHARMAPAR INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 3X10 |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-12-14 |
Estimated end date | 2021-01-29 |
Actual end date | 2021-01-22 |
Shortage status | Resolved |
Updated date | 2021-01-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-01-23 | English | Compare |
v4 | 2021-01-22 | French | Compare |
v3 | 2021-01-22 | English | Compare |
v2 | 2020-12-15 | French | Compare |
v1 | 2020-12-15 | English | Compare |
Showing 1 to 5 of 5